In treatment-naive DLBCL adults, a high M-MDSC surface expression of TREM2 is a poor prognostic factor for both PFS and OS, highlighting TREM2 as a potential therapeutic target. Here, TREM2 is linked to diffuse large B-cell lymphoma.